BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6600804)

  • 1. Metronidazole.
    Rosenblatt JE; Edson RS
    Mayo Clin Proc; 1983 Mar; 58(3):154-7. PubMed ID: 6600804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symposium on antimicrobial agents. Metronidazole.
    Rosenblatt JE; Edson RS
    Mayo Clin Proc; 1987 Nov; 62(11):1013-7. PubMed ID: 3312851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronidazole: in vitro activity, pharmacology and efficacy in anaerobic bacterial infections.
    Tally FP; Sullivan CE
    Pharmacotherapy; 1981; 1(1):28-38. PubMed ID: 6927601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro and in-vivo activity of metronidazole against Gardnerella vaginalis, Bacteroides spp. and Mobiluncus spp. in bacterial vaginosis.
    Jones BM; Geary I; Alawattegama AB; Kinghorn GR; Duerden BI
    J Antimicrob Chemother; 1985 Aug; 16(2):189-97. PubMed ID: 3905748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative susceptibilities of Gardnerella vaginalis (Haemophilus vaginalis), Neisseria gonorrhoeae, and Bacteroides fragilis to Metronidazole and its two major metabolites.
    Ralph ED; Amatnieks YE
    Sex Transm Dis; 1980; 7(4):157-60. PubMed ID: 6779387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative antimicrobial activity of metronidazole and the hydroxy metabolite against Gardnerella vaginalis.
    Ralph ED
    Scand J Infect Dis Suppl; 1983; 40():115-20. PubMed ID: 6607518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of Gardnerella vaginalis and anaerobes. Etiology of nonspecific colpitis].
    Hammann R; Lang N; Werner H
    Fortschr Med; 1984 Mar; 102(10):255-8. PubMed ID: 6370810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole.
    Pheifer TA; Forsyth PS; Durfee MA; Pollock HM; Holmes KK
    N Engl J Med; 1978 Jun; 298(26):1429-34. PubMed ID: 306577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronidazole. A therapeutic review and update.
    Freeman CD; Klutman NE; Lamp KC
    Drugs; 1997 Nov; 54(5):679-708. PubMed ID: 9360057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of pristinamycin and its components against gram-negative anaerobic bacilli and Gardnerella vaginalis.
    Weber P; Dubois S; Boussougant Y
    J Antimicrob Chemother; 1989 Jun; 23(6):825-30. PubMed ID: 2503487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of metronidazole treatment on the vaginal microbiological flora.
    Fredricsson B; Nord CE
    Scand J Infect Dis Suppl; 1983; 40():91-4. PubMed ID: 6607526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single oral dose metronidazole therapy for Gardnerella vaginalis vaginitis in adolescent females.
    Minkowski WL; Baker CJ; Alleyne D; Baghai M; Friedlander L; Schultz B
    J Adolesc Health Care; 1983 Jun; 4(2):113-6. PubMed ID: 6345494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Gardnerella vaginalis and Bacteroides organisms, associated with nonspecific vaginitis, to sulfonamide preparations.
    Jones BM; Kinghorn GR; Geary I
    Antimicrob Agents Chemother; 1982 Jun; 21(6):870-2. PubMed ID: 6981374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-specific vaginitis or vaginitis of undetermined aetiology.
    Faro S; Phillips LE
    Int J Tissue React; 1987; 9(2):173-7. PubMed ID: 3497132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gardnerella vaginalis and anaerobic bacteria in the etiology of bacterial (nonspecific) vaginosis.
    Spiegel CA; Davick P; Totten PA; Chen KC; Eschenbach DA; Amsel R; Holmes KK
    Scand J Infect Dis Suppl; 1983; 40():41-6. PubMed ID: 6607521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacteriological and clinical studies on metronidazole in Bacteroides fragilis infections (author's transl)].
    Shimada K; Inamatsu T; Sato K
    Jpn J Antibiot; 1979 Feb; 32(2):191-4. PubMed ID: 439390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronidazole in treatment of non-specific vaginitis. Clinical and microbiological findings in ten patients given 2 grams of metronidazole.
    Blackwell A; Fox A; Phillips I; Barlow D
    Scand J Infect Dis Suppl; 1983; 40():103-6. PubMed ID: 6607516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Nov; 16(5):387-417. PubMed ID: 363399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-specific vaginitis: diagnostic features and response to imidazole therapy (metronidazole, ornidazole).
    Meech RJ; Loutit J
    N Z Med J; 1985 May; 98(779):389-91. PubMed ID: 3887255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of tinidazole against anaerobes in comparison with metronidazole, ornidazole, cefoxitin and lamoxactam].
    Werner H; Kuchenbecker K; Hammann R
    Immun Infekt; 1983 Jun; 11(4):143-7. PubMed ID: 6681175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.